Mercator MedSystems

San Leandro, United States Founded: 2000 • Age: 26 yrs
Catheter-guided microfluid injection systems are developed for targeted tissue therapies.
Request Access

About Mercator MedSystems

Mercator MedSystems is a company based in San Leandro (United States) founded in 2000.. Mercator MedSystems has raised $31.8 million across 5 funding rounds from investors including HHS, Shenzhen Xinlitai Pharmaceutical and Volcano Capital Management. Mercator MedSystems offers products and services including Bullfrog Micro-Infusion Device. Mercator MedSystems operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Insulet, Alnylam and ATAI, among others.

  • Headquarter San Leandro, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Mercator Medsystems, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $31.8 M (USD)

    in 5 rounds

  • Latest Funding Round
    $14.3 M (USD), Series D

    Jun 17, 2019

  • Investors
    HHS

    & 4 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Mercator MedSystems

Mercator MedSystems offers a comprehensive portfolio of products and services, including Bullfrog Micro-Infusion Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Delivers drugs directly to vessel walls for targeted vascular treatments.

People of Mercator MedSystems
Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Kirk Seward
Founder, President And CEO
People
Steve Baker
Chief Financial Officer

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Mercator MedSystems

Mercator MedSystems has successfully raised a total of $31.8M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $14.3 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series D — $14.3M
  • First Round

    (11 Sep 2009)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2019 Amount Series D - Mercator MedSystems Valuation

investors

Jun, 2018 Amount Series D - Mercator MedSystems Valuation Shenzhen Xinlitai Pharmaceutical
Jun, 2013 Amount Series B - Mercator MedSystems Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Mercator MedSystems

Mercator MedSystems has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Shenzhen Xinlitai Pharmaceutical and Volcano Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Tech and life sciences focused VC firm investing in geographies such as the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Mercator MedSystems

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Mercator MedSystems

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mercator Medsystems Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Mercator MedSystems

Mercator MedSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Insulet, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
domain founded_year HQ Location
Gene therapies for rare diseases including retinal dystrophies are developed.
domain founded_year HQ Location
Wearable insulin infusion systems are developed for diabetes patients.
domain founded_year HQ Location
RNA interference-based therapeutics are developed for multiple disorders.
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mercator Medsystems

Frequently Asked Questions about Mercator MedSystems

When was Mercator MedSystems founded?

Mercator MedSystems was founded in 2000 and raised its 1st funding round 9 years after it was founded.

Where is Mercator MedSystems located?

Mercator MedSystems is headquartered in San Leandro, United States. It is registered at San Leandro, California, United States.

Is Mercator MedSystems a funded company?

Mercator MedSystems is a funded company, having raised a total of $31.8M across 5 funding rounds to date. The company's 1st funding round was a Series B of $6.5M, raised on Sep 11, 2009.

What does Mercator MedSystems do?

Mercator MedSystems was founded in 2000 and is based in San Leandro, United States. Micro-infusion catheters are developed by the company for non-systemic injection of therapeutic agents through blood vessel walls into deep tissues. These systems support applications in plaque stabilization for diseased vessels, anti-tumor drug delivery, growth factor administration for cell stimulation, and stem cell or gene therapies. Operations focus on vascular diseases, hypertension, oncology, and regenerative medicine sectors.

Who are the top competitors of Mercator MedSystems?

Mercator MedSystems's top competitors include Spark Therapeutics, BridgeBio and Insulet.

What products or services does Mercator MedSystems offer?

Mercator MedSystems offers Bullfrog Micro-Infusion Device.

Who are Mercator MedSystems's investors?

Mercator MedSystems has 5 investors. Key investors include HHS, Shenzhen Xinlitai Pharmaceutical, Volcano Capital Management, Crocker Capital, and Aphelion Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available